Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1970 1
1971 1
1972 1
1973 1
1975 3
1976 1
1977 3
1978 3
1979 2
1980 2
1981 3
1982 8
1983 6
1984 15
1985 11
1986 16
1987 17
1988 12
1989 18
1990 18
1991 24
1992 24
1993 28
1994 21
1995 22
1996 24
1997 30
1998 17
1999 32
2000 39
2001 40
2002 21
2003 19
2004 33
2005 31
2006 24
2007 22
2008 33
2009 31
2010 32
2011 31
2012 34
2013 31
2014 25
2015 36
2016 45
2017 52
2018 47
2019 37
2020 34
2021 55
2022 51
2023 52
2024 44
2025 44
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,220 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chibana h[au] (131 results)?
Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults.
Shirata M, Ito I, Ishida T, Tachibana H, Tanabe N, Konishi S, Oi I, Hamao N, Nishioka K, Matsumoto H, Yasutomo Y, Kadowaki S, Ohnishi H, Tomioka H, Nishimura T, Hasegawa Y, Nakagawa A, Hirai T. Shirata M, et al. Among authors: tachibana h. Sci Rep. 2021 Dec 13;11(1):23878. doi: 10.1038/s41598-021-03440-3. Sci Rep. 2021. PMID: 34903833 Free PMC article.
Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies.
Lu Z, Verginadis I, Kumazoe M, Castillo GM, Yao Y, Guerra RE, Bicher S, You M, McClung G, Qiu R, Xiao Z, Miao Z, George SS, Beiting DP, Nojiri T, Tanaka Y, Fujimura Y, Onda H, Hatakeyama Y, Nishimoto-Ashfield A, Bykova K, Guo W, Fan Y, Buynov NM, Diehl JA, Stanger BZ, Tachibana H, Gade TP, Puré E, Koumenis C, Bolotin EM, Fuchs SY. Lu Z, et al. Among authors: tachibana h. Sci Transl Med. 2024 Aug 21;16(761):eadn0904. doi: 10.1126/scitranslmed.adn0904. Epub 2024 Aug 21. Sci Transl Med. 2024. PMID: 39167664 Free PMC article.
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).
Bando H, Kumagai S, Kotani D, Mishima S, Irie T, Itahashi K, Tanaka Y, Habu T, Fukaya S, Kondo M, Tsushima T, Hara H, Kadowaki S, Kato K, Chin K, Yamaguchi K, Kageyama SI, Hojo H, Nakamura M, Tachibana H, Wakabayashi M, Fukui M, Fuse N, Koyama S, Mano H, Nishikawa H, Shitara K, Yoshino T, Kojima T. Bando H, et al. Among authors: tachibana h. Nat Cancer. 2025 Mar;6(3):445-459. doi: 10.1038/s43018-025-00918-1. Epub 2025 Feb 19. Nat Cancer. 2025. PMID: 39972105 Free PMC article. Clinical Trial.
[Comorbidity in migraine].
Tachibana H. Tachibana H. Rinsho Shinkeigaku. 2022 Feb 19;62(2):105-111. doi: 10.5692/clinicalneurol.cn-001698. Epub 2022 Jan 31. Rinsho Shinkeigaku. 2022. PMID: 35095052 Japanese.
Comprehensive Self-Management of Heart Failure.
Kiuchi S, Tsukamoto S, Sato R, Hosono K, Okuda J, Natsumeda M, Kawamura M, Tachibana H, Okada T, Takagi T, Taniguchi Y, Ando J, Koyama Y, Shinke T, Ikeda T. Kiuchi S, et al. Among authors: tachibana h. J Cardiovasc Dev Dis. 2025 Mar 20;12(3):107. doi: 10.3390/jcdd12030107. J Cardiovasc Dev Dis. 2025. PMID: 40137105 Free PMC article. Review.
Decreased circulating branched-chain amino acids are associated with development of Alzheimer's disease in elderly individuals with mild cognitive impairment.
Ikeuchi T, Kanda M, Kitamura H, Morikawa F, Toru S, Nishimura C, Kasuga K, Tokutake T, Takahashi T, Kuroha Y, Miyazawa N, Tanaka S, Utsumi K, Ono K, Yano S, Hamano T, Naruse S, Yajima R, Kawashima N, Kaneko C, Tachibana H, Yano Y, Kato Y, Toue S, Jinzu H, Kitamura A, Yokoyama Y, Kaneko E, Yamakado M, Nagao K. Ikeuchi T, et al. Among authors: tachibana h. Front Nutr. 2022 Dec 14;9:1040476. doi: 10.3389/fnut.2022.1040476. eCollection 2022. Front Nutr. 2022. PMID: 36590218 Free PMC article.
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data.
Ishihara H, Omae K, Nemoto Y, Ishiyama R, Tachibana H, Nishimura K, Ikeda T, Kobari Y, Fukuda H, Yoshida K, Shimmura H, Hashimoto Y, Iizuka J, Kondo T, Takagi T. Ishihara H, et al. Among authors: tachibana h. Int J Clin Oncol. 2024 Apr;29(4):473-480. doi: 10.1007/s10147-024-02471-w. Epub 2024 Feb 12. Int J Clin Oncol. 2024. PMID: 38345708
Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
Homma A, Mikami M, Matsuura K, Onimaru R, Yoshida D, Shinomiya H, Ohkoshi A, Hayashi R, Saito Y, Tachibana H, Shiga K, Ueda T, Uemura H, Nakamura K, Fukuda H; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). Homma A, et al. Among authors: tachibana h. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1271-1281. doi: 10.1016/j.ijrobp.2023.11.031. Epub 2023 Nov 24. Int J Radiat Oncol Biol Phys. 2024. PMID: 38008195 Free article.
Relapsing Polychondritis and Aseptic Meningoencephalitis.
Yokota K, Tachibana H, Miyake A, Yamamoto T, Mimura T. Yokota K, et al. Among authors: tachibana h. Intern Med. 2023 Feb 1;62(3):481-486. doi: 10.2169/internalmedicine.9411-22. Epub 2022 Jul 14. Intern Med. 2023. PMID: 35831110 Free PMC article.
1,220 results